参考文献/References:
[1].Yamamoto E,Sugiyama S,Hirata Y,et al.Prognostic significance of circulating leukocyte subtype counts in patients with coronary artery disease[J].Atherosclerosis,2016,255:210-216.
[2].Horne BD,Anderson JL,John JM,et al.Which white blood cell subtypes predict increased cardiovascular risk[J].J Am Coll Cardiol,2005,45(10):1638-1643.
[3].Nunez J,Minana G,Bodi V,et al.Low lymphocyte count and cardiovascular diseases[J].Curr Med Chem,2011,18(21):3226-3233.
[4].Greene SJ,Harinstein ME,Vaduganathan M,et al.Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial)[J].Am J Cardiol,2012,110(11):1657-1662.
[5].Arnett DK, Blumenthal RS,Albert MA,et al.2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease:a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines[J].Circulation,2019,140(11):e596-e646.
[6].Gensini GG. A more meaningful scoring system for determining the severity of coronary heart Disease[J]. Am J Cardiol,1983,51(3):606.
[7].王春,秦少博,李萍.炎症与血管内皮损伤研究进展[J].心血管病学进展,2015,36(1):89-92.
[8].Duewell P,Kono H,Rayner KJ,et al.NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals[J].Nature,2010,464(7293):1357-1361.
[9].Fayad ZA,Swirski FK,Calcagno C,et al.Monocyte and macrophage dynamics in the cardiovascular system:JACC Macrophage in CVD Series (Part 3)[J].J Am Coll Cardiol,2018,72(18):2198-2212.
[10].Flynn MC,Pernes G,Lee MKS,et al. Monocytes,macrophages,and metabolic disease in atherosclerosis[J]. Front Pharmacol,2019,10:00666.
[11].Herrero-Fernandez B,Gomez-Bris R,Somovilla-Crespo B,et al.Immunobiology of atherosclerosis:a complex net of interactions[J].Int J Mol Sci,2019,20(21):5293.
[12].Cioca DP,Watanabe N,Isobe M,et al.Apoptosis of peripheral blood lymphocytes is induced by catecholamines[J].Jpn Heart J,2000,41(3):385-398.
[13].Hu P,Shen H,Wang G,et al.Prognostic significance of systemic inflammation-based lymphocyte-monocyte ratio in patients with lung cancer:based on a large cohort study[J].PLoS One,2014,9(9):e108062.
[14].Gary T,Pichler M,Belaj K,et al.Lymphocyte-to-monocyte ratio:a novel marker for critical limb ischemia in PAOD patients[J].Int J Clin Pract,2014,68(12):1483-1487.
[15].Kurtul A,Yarlioglues M,Celik IE,et al.Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction[J].Coron Artery Dis,2015,26(8):706-712.
[16].Murat SN,Yarlioglues M,Celik IE,et al.The relationship between lymphocyte-to-monocyte ratio and bare-metal stent in-stent restenosis in patients with stable coronary artery disease[J].Clin Appl Thromb Hemost,2017,23(3):235-240.
[17].Ji H,Li Y,Fan Z,et al.Monocyte/lymphocyte ratio predicts the severity of coronary artery disease:a syntax score assessment[J].BMC Cardiovasc Disord,2017,17(1):90.
[18].柳强,胡有志,薛雪.冠心病患者单核细胞/淋巴细胞比率与冠状动脉病变严重程度的相关性分析[J].中国动脉硬化杂志,2019,27(10):868-872.